27
REBRANDING HEMP FOR THE NUTRACEUTICAL MARKET CANTERPENE AS A HEALTHSPAN EXTENSION SUPPLEMENT

Canterpene business-pitch-23oct-2012

Embed Size (px)

Citation preview

Page 1: Canterpene business-pitch-23oct-2012

REBRANDING HEMP FOR THE NUTRACEUTICAL

MARKET

CANTERPENE AS A HEALTHSPAN EXTENSION

SUPPLEMENT

Page 2: Canterpene business-pitch-23oct-2012

Original CANTERPENE concept Presented at :Canadian Hemp Trade Alliance Nov 15-17, 2010

Annual Conference Winnipeg , Manitoba , Canada

Page 3: Canterpene business-pitch-23oct-2012

REBRAND CANADIAN HEMP AS REBRAND CANADIAN HEMP AS CANTERPENECANTERPENE

We link Canadian Hemp with the messages:

“Extend Health-span and Lifespan naturally with cannabis chemistry”

Canterpene expands functional chemistry beyond arginine and omega3’s to include cannabinoids and terpenes

Page 4: Canterpene business-pitch-23oct-2012

NUMEROUS BIOCHEMICAL BENEFITS OF CANNABINOIDS IN HEMP

Page 5: Canterpene business-pitch-23oct-2012

Canterpene is a source of supplemental terpenes

Many terpenes exhibit health benefits

Page 6: Canterpene business-pitch-23oct-2012

Chemo-profiles of some cannabis varieties

Page 7: Canterpene business-pitch-23oct-2012

Terry Grossman,M.D. Medical Director

Morris Johnson, CTO, Founder

Silas Kanning,

Co-founders of:

Lifespan Pharma Inc.

Page 8: Canterpene business-pitch-23oct-2012

REBRANDING HEMP AS CANTERPENE MAKES SENSE FOR THE NATURAL HEALTH PRODUCT /

DSHEA FOOD SUPPLEMENT MARKETS

Page 9: Canterpene business-pitch-23oct-2012

Lifespan Pharma IncSW34-01-16-W2nd meridian

Box 10 Beaubier, Sk., [email protected]

701-240-9411

Page 10: Canterpene business-pitch-23oct-2012

Hemp is undergoing a similar identity Hemp is undergoing a similar identity crisiscrisis i in the minds of many todayn the minds of many today

Page 11: Canterpene business-pitch-23oct-2012

WE HAVE PATENTED CANTERPENE WE HAVE PATENTED CANTERPENE AS A PROPRIETARY FORMULATION AS A PROPRIETARY FORMULATION

OF MILLED HEMPSEEDOF MILLED HEMPSEED

Page 12: Canterpene business-pitch-23oct-2012

CANADIAN HEMP IS LEGAL AND EXEMPT FROM SCHEDULE 1 REGULATION AS IT IS NEITHER HERBAL

MARIJUANA NOR SYNTHETIC THC

Page 13: Canterpene business-pitch-23oct-2012

THIS GIVES US A MONOPOLY OVER ALL HEMP CHEMISTRY NOT SPECIFIC TO

OIL AND MEALThe only conditions under which non seed material can leave the Canadian farms are captured by the patent

Intellectual property rights can be enforced by USA and Canadian border security agents

USA government regulators prefer a captive regulated imported hemp supply that is segregated from their domestic illegal unregulated cannabis market

Our goal is to expand Canadian hemp production from 50,000 acres now to 500,000 acres within 5 years and capture 80% of the supply chain from farm to distribution of finished goods as nutraceuticals compounded with Canterpene

Page 14: Canterpene business-pitch-23oct-2012

CANTERPENE IS A SOUND INVESTMENT INTO PERSONAL

PREVENTATIVE MEDICINE The medical marijuna market is technically illegal but its existence demonstrates the USA consumer’s willingness to pay billions of dollars for cannabis nutraceutical supplements.

The economics of growing hemp by the square mile and processing hemp by the ton deliver a product that is economical enough to be consumed in quantities sufficient to be an efficacious nutraceutical

Page 15: Canterpene business-pitch-23oct-2012

CANTERPENE PROCESSING ALGORITHMProcessing consists of using a set of portable processing skids on the farm to:

A :cut and bale and put through a combine harvester or cut and process using a dehydration and pelleting procedure to produce an inseparable grain/biomass patent compliant mixture

B: remill to a fine powder with a Comitrol mill

C: combine with ethanol/water/orange oil solvents to crack the bioactives by sufficient agitation of a slurry

D: extract hemp oil/bioactive liquid with a decanting centrifuge and reflux extract by repeating step C to concentrate the bioactives.

E: combine oil with other ingredients and encapsulate/bottle/label/package and distribute to retailer

Page 16: Canterpene business-pitch-23oct-2012

MSRP ~ 40.00/ BOTTLE OF 100 750 MG CAPSULES1-INGREDIENTS – COMPOSITE VALUE OF INGREDIENTS 11.00/BOTTLE = (410.00/GALLON OR 50.00/POUND) -60/GALLON -TO COST OF GROWING CROP -160/GALLON -TO BUILD AND OPERATE AND EXPAND FACILITIES AND EQUIPMENT FLEET TO CONVERT CROP IN THE FIELD TO OIL/EXTRACT/DERIVATIVES -90/GALLON -TO PHYTOCHEMICAL R&D/CLINICAL TRIALS -100/GALLON -TO OVERHEAD/TAXES/RETURN TO INVESTORS2-ENCAPSULATION/PKGING./BOTTELING /LABELING -9.00/BTL3-MARKETING -15.00/BOTTLE4-DISTRIBUTION/SHIPPING -5.00/BOTTLE AS WE SCALE UP , WE WORK EFFICIENCIES INTO EACH LINE ITEM TO PROVIDE INVESTORS WITH A PROPER RETURN ON INVESTMENT ….DETAILS IN OUR BUSINESS PLAN

THE BOTTOM LINE:25-35% TARGET RETURN ON INVESTMENT

Page 17: Canterpene business-pitch-23oct-2012

CANTERPENE CAN HELP AS A PREVENTIVE ANTIAGING STRATEGY

Science has linked numerous compounds Science has linked numerous compounds found in Canterpene with beneficial effects found in Canterpene with beneficial effects on the diseases resulting from “normal” on the diseases resulting from “normal” agingaging

Canterpene captures much that other Canterpene captures much that other conventional hemp supplements have conventional hemp supplements have ignored…….ignored…….http://www.slideshare.net/lifespan.pharma.inc/canterpene-hemp-based-nutraceutical-formulations/download

Page 18: Canterpene business-pitch-23oct-2012

DSHEA COMPLIANT TARGETS -Optimize the broad spectrum of Canterpene functionalities

-Add phytochemistry to enhance each functionality

-Utilize ingredients with both ethnobotanical and modern pharmacological support in peer-reviewed , published literature

-Proprietary varietal selection and agronomic production practices allow the use of the same Canterpene ingredient for several distinctly different formulations

-10 unique formulas can be combined into an individualized therapeutic program to attack a systemic problem, AGING

“Medicine without a market benefits no one”

Page 19: Canterpene business-pitch-23oct-2012

DOES CANTERPENE HAVE A MARKET?

-Healthspan extension and lifespan optimization are new unmet needs

-Personalized /Individualized Medicine is an emerging Industry

-”Bockbuster” Pharma is migrating towards “Niche” Pharma

-Canterpene Cannabis without THC contains phyto-chemistry which scientific research indicates would make it a

useful food supplement for:

“personalized management of Aging “

Page 20: Canterpene business-pitch-23oct-2012

ANTIAGING IS AN ENORMOUS MARKET

76 million baby boomers in the US

6 million “boomies” in Canada

Boomers now 48 – 64 and have begun to experience the “aging process” firsthand

This generation has redefined each stage of their lives and is currently redefining aging

Page 21: Canterpene business-pitch-23oct-2012

BOOMERS REGARD AGING AS A DISEASE …

Page 22: Canterpene business-pitch-23oct-2012

… THAT AFFECTS EVERYONE

Page 23: Canterpene business-pitch-23oct-2012

… AND IS 100 PERCENT FATAL

Page 24: Canterpene business-pitch-23oct-2012

AGING , A SYSTEMIC DEGENERATIVE SYNDROME WITH MULTIPLE THERAPEUTIC TARGETS HTTP://WWW.YOUTUBE.COM/WATCH?V=GHVXW2EE3-A

Page 25: Canterpene business-pitch-23oct-2012

THE TWO PILLARS OF HEALTH

Prevention EarlyDetection

Page 26: Canterpene business-pitch-23oct-2012

The name of the game is to “beat this clock”

Page 27: Canterpene business-pitch-23oct-2012

CANTERPENE BENEFITS EVERYONE IN THE SUPPLY

CHAIN FROM THE FARMER TO THE CONSUMER

GOOD SCIENCE WITHOUT A GOOD SCIENCE WITHOUT A METHOD TO COMMERCIALIZE IT METHOD TO COMMERCIALIZE IT

WILL NOT BENEFIT ANYONEWILL NOT BENEFIT ANYONE